RecallDepth
Class II Ongoing

Tri-Moxi+¿ (Triamcinolone 9mg/0.6mL, Moxifloxacin 0.6 mg/ 0.6 mL) Single-Use Intraocular Injection, Imprimis NJOF, LLC., 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852. NDC 71384-746-06.

Company
Imprimis Njof, Llc
Recall Initiated
December 18, 2025
Posted
January 14, 2026
Recall Number
D-0251-2026
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
314 boxes of 6,280 pre-filled syringes
Firm Location
Ledgewood, NJ, United States

Reason for Recall

Presence of particulate matter - Glass like particles.

Distribution

U.S Nationwide

Lot / Code Info

Lot: 25JAN033A, 25JAN033B, Expires: 02/12/2026.

More recalls by Imprimis Njof, Llc

View all recalls by this company →

Other recent Class II Drug recalls